Cargando…
PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
The present study reveals a link between protein arginine methyltransferase 5 (PRMT5) and Homebox A9 (HoxA9) in the regulation of cardiomyocyte hypertrophy. In cardiomyocyte hypertrophy induced by β-adrenergic receptor agonist isoprenaline (ISO), PRMT5 expression was decreased while HoxA9 was upregu...
Autores principales: | Cai, Sidong, Liu, Rong, Wang, Panxia, Li, Jingyan, Xie, Tingting, Wang, Minghui, Cao, Yanjun, Li, Zhuoming, Liu, Peiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793800/ https://www.ncbi.nlm.nih.gov/pubmed/33424610 http://dx.doi.org/10.3389/fphar.2020.600627 |
Ejemplares similares
-
HoxA9 binds and represses the Cebpa +8 kb enhancer
por: Peng, Lei, et al.
Publicado: (2019) -
HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia
por: Brumatti, Gabriela, et al.
Publicado: (2013) -
The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of HoxA7 and HoxA9
por: Fisher, Joseph B., et al.
Publicado: (2016) -
Regulation of CDX4 gene transcription by HoxA9, HoxA10, the Mll-Ell oncogene and Shp2 during leukemogenesis
por: Bei, L, et al.
Publicado: (2014) -
Hox in motion: tracking HoxA cluster conformation during differentiation
por: Rousseau, Mathieu, et al.
Publicado: (2014)